IS4516A - Nýtt lyfjaform - Google Patents

Nýtt lyfjaform

Info

Publication number
IS4516A
IS4516A IS4516A IS4516A IS4516A IS 4516 A IS4516 A IS 4516A IS 4516 A IS4516 A IS 4516A IS 4516 A IS4516 A IS 4516A IS 4516 A IS4516 A IS 4516A
Authority
IS
Iceland
Prior art keywords
pharmaceutical preparation
human
relates
pharmaceutical form
present
Prior art date
Application number
IS4516A
Other languages
English (en)
Inventor
Gizurarson Sveinbjörn
Original Assignee
Gizurarson Sveinbjörn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36699744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4516(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gizurarson Sveinbjörn filed Critical Gizurarson Sveinbjörn
Priority to IS4516A priority Critical patent/IS4516A/is
Priority to AU81022/98A priority patent/AU739893B2/en
Priority to CA002298596A priority patent/CA2298596A1/en
Priority to DK98930657T priority patent/DK0991479T3/da
Priority to EP98930657A priority patent/EP0991479B1/en
Priority to DE69832070T priority patent/DE69832070T2/de
Priority to ES98930657T priority patent/ES2255165T3/es
Priority to AT98930657T priority patent/ATE307676T1/de
Priority to PCT/DK1998/000297 priority patent/WO1999001229A1/en
Priority to US09/446,931 priority patent/US6647980B1/en
Publication of IS4516A publication Critical patent/IS4516A/is

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
    • B05B1/02—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops, or having an outlet of particular shape
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/0005—Components or details
    • B05B11/0027—Means for neutralising the actuation of the sprayer ; Means for preventing access to the sprayer actuation means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/797—Lipid particle
    • Y10S977/798—Lipid particle having internalized material
    • Y10S977/799—Containing biological material
    • Y10S977/801—Drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Plastic Fillers For Packaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4516A 1997-07-01 1997-07-01 Nýtt lyfjaform IS4516A (is)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform
US09/446,931 US6647980B1 (en) 1997-07-01 1998-07-01 Method for administration of active substances to the olfactory region
EP98930657A EP0991479B1 (en) 1997-07-01 1998-07-01 An administration package unit for the delivery to the olfactory region
CA002298596A CA2298596A1 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region
DK98930657T DK0991479T3 (da) 1997-07-01 1998-07-01 Pakningsenhed til indgivelse til lugteområdet
AU81022/98A AU739893B2 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region
DE69832070T DE69832070T2 (de) 1997-07-01 1998-07-01 Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region
ES98930657T ES2255165T3 (es) 1997-07-01 1998-07-01 Unidad de envase de administracion para el suministro a la region olfativa.
AT98930657T ATE307676T1 (de) 1997-07-01 1998-07-01 Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region
PCT/DK1998/000297 WO1999001229A1 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform

Publications (1)

Publication Number Publication Date
IS4516A true IS4516A (is) 1999-01-02

Family

ID=36699744

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform

Country Status (10)

Country Link
US (1) US6647980B1 (is)
EP (1) EP0991479B1 (is)
AT (1) ATE307676T1 (is)
AU (1) AU739893B2 (is)
CA (1) CA2298596A1 (is)
DE (1) DE69832070T2 (is)
DK (1) DK0991479T3 (is)
ES (1) ES2255165T3 (is)
IS (1) IS4516A (is)
WO (1) WO1999001229A1 (is)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033598B2 (en) 1996-11-19 2006-04-25 Intrabrain International N.V. Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
DE10004547A1 (de) * 2000-02-02 2001-08-09 Liedtke Pharmed Gmbh Verfahren zur selektiven Verabreichung zentralnervös aktiver Stoffe
US6853858B2 (en) * 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
ATE359099T1 (de) * 2001-02-08 2007-05-15 Nasaleze Patents Ltd Gerät zur ausgabe von pulverförmigem material
US20050063940A1 (en) * 2002-02-25 2005-03-24 Sveinbjorn Gizurarson Bioadhesive agent
US8347879B2 (en) 2002-05-09 2013-01-08 Glaxo Group Limited Fluid dispensing device
US20040039352A1 (en) * 2002-06-28 2004-02-26 Paul Bergeson Nasal dosing device
WO2005016273A2 (en) * 2003-08-05 2005-02-24 3M Innovative Properties Company Infection prophylaxis using immune response modifier compounds
GB0405477D0 (en) 2004-03-11 2004-04-21 Glaxo Group Ltd A fluid dispensing device
CN1901958B (zh) * 2003-11-03 2011-03-09 葛兰素集团有限公司 流体分配装置
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
GB0507224D0 (en) 2005-04-09 2005-05-18 Glaxo Group Ltd A fluid dispensing device
WO2007064657A1 (en) * 2005-11-29 2007-06-07 Alza Corporation Nasal delivery device for the delivery of a substance to the olfactory region
WO2007083073A1 (en) * 2006-01-19 2007-07-26 Optinose As Nasal administration
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
US20080228162A1 (en) * 2007-03-16 2008-09-18 Medlmmune Vaccines, Inc. Single-use ampoule
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
WO2008137632A1 (en) * 2007-05-04 2008-11-13 The Procter & Gamble Company Antimicrobial compositions, products, and methods of use
CN101980738A (zh) 2008-02-07 2011-02-23 华盛顿大学 圆周气雾设备
RU2485982C1 (ru) 2009-05-19 2013-06-27 Эдуард Н. ЛЕРНЕР Устройство и способы улучшенной многократной доставки биологически активных веществ внутрь организма и для предотвращения местного раздражения
RU2612506C2 (ru) * 2011-03-03 2017-03-09 Импел Ньюрофарма Инк. Устройство для назальной доставки лекарственных средств
WO2012154859A1 (en) 2011-05-09 2012-11-15 Impel Neuropharma Inc. Nozzles for nasal drug delivery
EP2991713B1 (en) 2013-04-28 2019-06-19 Impel Neuropharma Inc. Medical unit dose container
GB201308679D0 (en) 2013-05-14 2013-06-26 3M Innovative Properties Co Actuator for an inhaler
NZ741171A (en) 2015-09-10 2022-01-28 Impel Neuropharma Inc In-line nasal delivery device
EP3713628A4 (en) 2017-11-21 2021-08-18 Impel Neuropharma Inc. INTRA-NASAL DEVICE WITH DIVER TUBE
CA3081680A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
JP7317020B2 (ja) 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達
US11278492B2 (en) 2018-01-05 2022-03-22 Impel Neuropharma, Inc. Intranasal delivery of olanzapine by precision olfactory device
JP2021532098A (ja) 2018-07-19 2021-11-25 インペル ニューロファーマ インコーポレイテッド パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達
AU2019418744B2 (en) 2019-01-03 2023-08-03 Impel Pharmaceuticals Inc. Nasal drug delivery device
BR112021023049A8 (pt) 2019-05-17 2022-10-18 Impel Neuropharma Inc Dispositivo de dispensação nasal de uso único
US20220339123A1 (en) * 2019-09-13 2022-10-27 Janssen Pharmaceuticals, Inc. Intranasal administration of esketamine
FR3120534B1 (fr) * 2021-03-09 2023-06-30 Aptar France Sas Tête de distribution nasale de produit fluide et dispositif comportant une telle tête

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3762409A (en) * 1970-11-03 1973-10-02 V Lester Nebulizer
US4054622A (en) * 1970-11-03 1977-10-18 Lester Victor E Combination nebulizer and humidifier
CH539556A (de) * 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
US3961756A (en) * 1975-02-10 1976-06-08 National Chemsearch Corporation Adjustable-spray mechanism
US4961727A (en) * 1988-11-16 1990-10-09 Beard Walter C Dispensing package
US5116315A (en) 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
WO1991007947A1 (en) 1989-12-05 1991-06-13 Ramsey Foundation Neurologic agents for nasal administration to the brain
DE4016126A1 (de) * 1990-04-17 1991-10-24 Coster Tecnologie Speciali Spa Vorrichtung zur transnasalen oder oralen verabreichung von medikamenten o. dgl.
WO1993002729A1 (en) * 1990-07-12 1993-02-18 Habley Medical Technology Corporation Super atomizing nonchlorinated fluorocarbon medication inhaler
DK198591D0 (da) * 1991-12-10 1991-12-10 Novo Nordisk As Apparat
US5525329A (en) 1992-05-21 1996-06-11 The Johns Hopkins University Inhibition of phosphodiesterase in olfactory mucosa
GB9405952D0 (en) * 1994-03-25 1994-05-11 Zeneca Ltd Aqueous ophthalmic sprays
FR2732318B1 (fr) * 1995-03-31 1997-04-25 Oreal Ditributeur aerosol a deux buses de pulverisation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
AU7669496A (en) 1995-11-03 1997-05-22 University Of Kentucky Method for the intranasal administration of l-dopa prodrugs
US5921233A (en) * 1997-09-04 1999-07-13 Pincgold Llc Liquid dispenser assembly particularly for medical applications

Also Published As

Publication number Publication date
EP0991479A1 (en) 2000-04-12
US6647980B1 (en) 2003-11-18
CA2298596A1 (en) 1999-01-14
ES2255165T3 (es) 2006-06-16
EP0991479B1 (en) 2005-10-26
WO1999001229A1 (en) 1999-01-14
AU739893B2 (en) 2001-10-25
DE69832070D1 (de) 2005-12-01
DK0991479T3 (da) 2006-03-13
DE69832070T2 (de) 2006-07-13
AU8102298A (en) 1999-01-25
ATE307676T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
DK0991479T3 (da) Pakningsenhed til indgivelse til lugteområdet
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
DK0799024T3 (da) Farmaceutisk aerosol indeholdende mindst en sukker
BR0108730A (pt) Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
ATE196081T1 (de) L-dopa ester enthaltende zusammensetzung
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
DK0630230T3 (da) Farmaceutiske inhaleringspræparater
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
NO952906D0 (no) Farmasöytisk formulering for behandling av nikotinavhengighet
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
KR950028767A (ko) 피부통과 투약을 위한 신규의 약제학적 투여 형태
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
DE69928806D1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
KR930019224A (ko) 유산 위험 치료제
WO1999020244A3 (de) Verfahren zur transdermalen applikation von wirkstoffen in hoher, konstanter dosierung
MY117960A (en) A new salt
IL164317A0 (en) Statin therapy for enhancing cognitive maintenance
KR960003741A (ko) 조골세포 증식인자
RU97116821A (ru) Способ лечения респираторных заболеваний